Cargando…

Longitudinal observation of insulin secretory ability before and after the onset of immune checkpoint inhibitor‐induced diabetes mellitus: A report of two cases

Immune checkpoint inhibitor‐induced diabetes mellitus is a rare immune‐related adverse event. This report illustrates clinical data and insulin secretory ability before and after the onset of immune checkpoint inhibitor‐induced diabetes.

Detalles Bibliográficos
Autores principales: Fujiwara, Noriko, Watanabe, Mayu, Katayama, Akihiro, Noda, Yohei, Eguchi, Jun, Kataoka, Hitomi, Kagawa, Shunsuke, Wada, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424178/
https://www.ncbi.nlm.nih.gov/pubmed/34522382
http://dx.doi.org/10.1002/ccr3.4574
_version_ 1783749620393836544
author Fujiwara, Noriko
Watanabe, Mayu
Katayama, Akihiro
Noda, Yohei
Eguchi, Jun
Kataoka, Hitomi
Kagawa, Shunsuke
Wada, Jun
author_facet Fujiwara, Noriko
Watanabe, Mayu
Katayama, Akihiro
Noda, Yohei
Eguchi, Jun
Kataoka, Hitomi
Kagawa, Shunsuke
Wada, Jun
author_sort Fujiwara, Noriko
collection PubMed
description Immune checkpoint inhibitor‐induced diabetes mellitus is a rare immune‐related adverse event. This report illustrates clinical data and insulin secretory ability before and after the onset of immune checkpoint inhibitor‐induced diabetes.
format Online
Article
Text
id pubmed-8424178
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84241782021-09-13 Longitudinal observation of insulin secretory ability before and after the onset of immune checkpoint inhibitor‐induced diabetes mellitus: A report of two cases Fujiwara, Noriko Watanabe, Mayu Katayama, Akihiro Noda, Yohei Eguchi, Jun Kataoka, Hitomi Kagawa, Shunsuke Wada, Jun Clin Case Rep Case Report Immune checkpoint inhibitor‐induced diabetes mellitus is a rare immune‐related adverse event. This report illustrates clinical data and insulin secretory ability before and after the onset of immune checkpoint inhibitor‐induced diabetes. John Wiley and Sons Inc. 2021-09-07 /pmc/articles/PMC8424178/ /pubmed/34522382 http://dx.doi.org/10.1002/ccr3.4574 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Fujiwara, Noriko
Watanabe, Mayu
Katayama, Akihiro
Noda, Yohei
Eguchi, Jun
Kataoka, Hitomi
Kagawa, Shunsuke
Wada, Jun
Longitudinal observation of insulin secretory ability before and after the onset of immune checkpoint inhibitor‐induced diabetes mellitus: A report of two cases
title Longitudinal observation of insulin secretory ability before and after the onset of immune checkpoint inhibitor‐induced diabetes mellitus: A report of two cases
title_full Longitudinal observation of insulin secretory ability before and after the onset of immune checkpoint inhibitor‐induced diabetes mellitus: A report of two cases
title_fullStr Longitudinal observation of insulin secretory ability before and after the onset of immune checkpoint inhibitor‐induced diabetes mellitus: A report of two cases
title_full_unstemmed Longitudinal observation of insulin secretory ability before and after the onset of immune checkpoint inhibitor‐induced diabetes mellitus: A report of two cases
title_short Longitudinal observation of insulin secretory ability before and after the onset of immune checkpoint inhibitor‐induced diabetes mellitus: A report of two cases
title_sort longitudinal observation of insulin secretory ability before and after the onset of immune checkpoint inhibitor‐induced diabetes mellitus: a report of two cases
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424178/
https://www.ncbi.nlm.nih.gov/pubmed/34522382
http://dx.doi.org/10.1002/ccr3.4574
work_keys_str_mv AT fujiwaranoriko longitudinalobservationofinsulinsecretoryabilitybeforeandaftertheonsetofimmunecheckpointinhibitorinduceddiabetesmellitusareportoftwocases
AT watanabemayu longitudinalobservationofinsulinsecretoryabilitybeforeandaftertheonsetofimmunecheckpointinhibitorinduceddiabetesmellitusareportoftwocases
AT katayamaakihiro longitudinalobservationofinsulinsecretoryabilitybeforeandaftertheonsetofimmunecheckpointinhibitorinduceddiabetesmellitusareportoftwocases
AT nodayohei longitudinalobservationofinsulinsecretoryabilitybeforeandaftertheonsetofimmunecheckpointinhibitorinduceddiabetesmellitusareportoftwocases
AT eguchijun longitudinalobservationofinsulinsecretoryabilitybeforeandaftertheonsetofimmunecheckpointinhibitorinduceddiabetesmellitusareportoftwocases
AT kataokahitomi longitudinalobservationofinsulinsecretoryabilitybeforeandaftertheonsetofimmunecheckpointinhibitorinduceddiabetesmellitusareportoftwocases
AT kagawashunsuke longitudinalobservationofinsulinsecretoryabilitybeforeandaftertheonsetofimmunecheckpointinhibitorinduceddiabetesmellitusareportoftwocases
AT wadajun longitudinalobservationofinsulinsecretoryabilitybeforeandaftertheonsetofimmunecheckpointinhibitorinduceddiabetesmellitusareportoftwocases